Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 3 (2006), Issue 11 (November)

1. Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.
   Br J Cancer, 95(9): 1195-201. [Abstract] [Full-text]
2. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.
   Int J Cancer, 119(12): 2724-32. [Abstract] [Full-text]
3. Modulation of oncogenic transcription and alternative splicing by beta-catenin and an RNA aptamer in colon cancer cells.
   Cancer Res, 66(21): 10560-6. [Abstract] [Full-text]
4. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
   Oncogene, 25(52): 6959-67. [Abstract] [Full-text]
5. Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.
   Cancer Sci, 97(12): 1410-6. [Abstract] [Full-text]
6. Cell number-dependent regulation of Hsp70B' expression: evidence of an extracellular regulator.
   J Cell Physiol, 210(1): 201-11. [Abstract] [Full-text]
7. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer.
   Int J Cancer, 120(1): 207-11. [Abstract] [Full-text]
8. Ruptured appendiceal cystadenoma presenting as right inguinal hernia in a patient with left colon cancer: a case report and review of literature.
   BMC Gastroenterol, 6: 32. [Abstract] [Full-text]
9. Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis.
   Biochem Pharmacol, 72(11): 1396-404. [Abstract] [Full-text]
10. Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2.
    Am J Physiol Gastrointest Liver Physiol, 291(6): G1100-12. [Abstract] [Full-text]
11. Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis.
    Bioorg Med Chem Lett, 16(23): 6131-4. [Abstract] [Full-text]
12. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Gastroenterology, 131(5): 1486-500. [Abstract] [Full-text]
13. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
    Gastroenterology, 131(5): 1400-7. [Abstract] [Full-text]
14. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    J Natl Cancer Inst, 98(22): 1647-54. [Abstract] [Full-text]
15. Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia.
    Leuk Res, 31(1): 105-8. [Abstract] [Full-text]
16. Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell lines.
    J Surg Res, 136(2): 227-31. [Abstract] [Full-text]
17. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Cancer, 107(11): 2581-8. [Abstract] [Full-text]
18. Genetic testing for colon cancer.
    Nat Clin Pract Gastroenterol Hepatol, 3(12): 670-9. [Abstract] [Full-text]
19. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethane-induced colon cancer in Fisher 344 male rats.
    Food Chem Toxicol, 45(1): 153-9. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.